• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伦敦南部一家教学医院中对庆大霉素高度耐药的粪肠球菌的患病率及易感性

Prevalence and susceptibility of highly gentamicin resistant Enterococcus faecalis in a south London teaching hospital.

作者信息

Smyth E G, Stevens P J, Holliman R E

机构信息

Department of Medical Microbiology, St. George's Hospital Medical School, London, UK.

出版信息

J Antimicrob Chemother. 1989 Apr;23(4):633-9. doi: 10.1093/jac/23.4.633.

DOI:10.1093/jac/23.4.633
PMID:2501271
Abstract

Combinations of aminoglycosides plus ampicillin usually are necessary for the satisfactory management of serious Enterococcus faecalis sepsis. A study in a South London hospital demonstrated that 7% of all E. faecalis, and 30% of those from blood cultures, were highly gentamicin resistant. Addition of gentamicin confers no benefit to the treatment of these organisms with ampicillin. We looked at the susceptibility pattern of these organisms in vitro and concluded that ampicillin plus ciprofloxacin offered the best available combination.

摘要

氨基糖苷类药物与氨苄西林联合使用通常是有效治疗严重粪肠球菌败血症所必需的。伦敦南部一家医院的一项研究表明,所有粪肠球菌中有7%,血培养分离出的粪肠球菌中有30%对庆大霉素高度耐药。对于用氨苄西林治疗这些细菌,添加庆大霉素并无益处。我们研究了这些细菌的体外药敏模式,得出氨苄西林加环丙沙星是最佳联合用药方案的结论。

相似文献

1
Prevalence and susceptibility of highly gentamicin resistant Enterococcus faecalis in a south London teaching hospital.伦敦南部一家教学医院中对庆大霉素高度耐药的粪肠球菌的患病率及易感性
J Antimicrob Chemother. 1989 Apr;23(4):633-9. doi: 10.1093/jac/23.4.633.
2
In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.氨苄西林与庆大霉素、头孢曲松和环丙沙星对粪肠球菌的体外协同作用。
Int J Antimicrob Agents. 2014 Jul;44(1):85-6. doi: 10.1016/j.ijantimicag.2014.03.011. Epub 2014 May 2.
3
Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.
Chemotherapy. 1993 Mar-Apr;39(2):82-7. doi: 10.1159/000239107.
4
Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.阿根廷一家大学医院中粪肠球菌对十二种抗生素的敏感性、时间杀菌试验及高水平氨基糖苷类耐药性
Rev Argent Microbiol. 1991 Apr-Jun;23(2):67-78.
5
In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.氨苄西林与阿贝卡星联合用药对高水平庆大霉素耐药肠球菌的体外活性
J Antimicrob Chemother. 1998 Dec;42(6):836-8. doi: 10.1093/oxfordjournals.jac.a020872.
6
Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.氨苄西林与头孢洛林、头孢吡肟或头孢曲松联合使用在高接种量粪肠球菌感染模型中显示出同等活性。
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3178-82. doi: 10.1128/AAC.03126-15. Print 2016 May.
7
Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.出现对多种氨基环醇类氨基糖苷具有高水平抗性的粪肠球菌分离株。
Diagn Microbiol Infect Dis. 1984 Jun;2(3):171-7. doi: 10.1016/0732-8893(84)90027-0.
8
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.达托霉素(LY 146032)与四种对照抗生素单独及联合使用时,对庆大霉素敏感和高水平庆大霉素耐药肠球菌的体外抑制和杀菌活性比较。
Chemotherapy. 1993 Sep-Oct;39(5):302-9. doi: 10.1159/000239141.
9
Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.氨苄西林联合头孢曲松和庆大霉素治疗对氨基糖苷类无高水平耐药的粪肠球菌所致实验性心内膜炎的疗效
J Antimicrob Chemother. 2003 Sep;52(3):514-7. doi: 10.1093/jac/dkg360. Epub 2003 Aug 13.
10
Epidemiology of high-level gentamicin resistant enterococcal isolates from Zimbabwe.津巴布韦高水平庆大霉素耐药肠球菌分离株的流行病学研究
Am J Trop Med Hyg. 1990 Oct;43(4):397-9. doi: 10.4269/ajtmh.1990.43.397.

引用本文的文献

1
High level resistance to aminoglycosides in enterococci from Riyadh.利雅得地区肠球菌对氨基糖苷类抗生素的高水平耐药性。
Ann Saudi Med. 1994 Jul;14(4):290-3. doi: 10.5144/0256-4947.1994.290.
2
Frequency and antimicrobial susceptibility of clinical isolates of enterococci.肠球菌临床分离株的频率及抗菌药敏性
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):362-6. doi: 10.1007/BF01964435.
3
Patterns of antibiotic resistance among enterococcal strains isolated from clinical specimens and food in Poland.
Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):69-71. doi: 10.1007/BF02112626.
4
Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.20世纪80年代肠球菌的易感性及肠球菌感染的流行病学。
Epidemiol Infect. 1989 Dec;103(3):403-13. doi: 10.1017/s0950268800030806.
5
Resistance to vancomycin and teicoplanin: an emerging clinical problem.对万古霉素和替考拉宁的耐药性:一个新出现的临床问题。
Clin Microbiol Rev. 1990 Jul;3(3):280-91. doi: 10.1128/CMR.3.3.280.
6
Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients.从住院患者中分离出的肠球菌的菌种鉴定及药敏试验。
Antimicrob Agents Chemother. 1991 Sep;35(9):1943-5. doi: 10.1128/AAC.35.9.1943.
7
Species identification and antibiotic resistance patterns of the enterococci.
Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):745-7. doi: 10.1007/BF01972500.